Alkem has received approval from the Drugs Controller General of India (DCGI) to manufacture and market the product for the management of Type 2 diabetes mellitus and obesity, alongside lifestyle modifications such as diet and exercise
They'll review your overall health and talk through any potential risks with you
But before we go down that path, one of the other things that has come out is that GLP-1s do seem to have other knock-on effects beyond weight loss and beyond diabetes, and so can you talk a little bit about some of the potential of GLP-1s for other health conditions
Common side effects that typically subside over time include: constipation, diarrhea, vomiting, nausea, or abdominal pain
Many individuals begin to notice changes in appetite and weight within a few weeks of starting treatment
The effects of GLP-1s on the gut microbiome still arent clear, but when digestion slows down too much, it can affect gut flora